Varenicline for Treatment of Alcohol Dependence: A Randomized, Placebo-Controlled Trial

Phosphatidylethanol is Superior to Carbohydrate-Deficient Transferrin andγ-Glutamyltransferase as an Alcohol Marker and is a Reliable Estimate of Alcohol Consumption Level

(2015) Lisa Walther et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals

(2014) Joseph P. Schacht et al.   PSYCHOPHARMACOLOGY

A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence

(2013) Antoni Gual et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence

(2013) Raye Z. Litten et al.   Journal of Addiction Medicine

Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed Nalmefene

(2012) Karl Mann et al.   BIOLOGICAL PSYCHIATRY

Varenicline decreases alcohol consumption in heavy-drinking smokers

(2012) Jennifer M. Mitchell et al.   PSYCHOPHARMACOLOGY

Phosphatidylethanol in blood (B-PEth): A marker for alcohol use and abuse

(2011) Anders Isaksson et al.   Drug Testing and Analysis

A preliminary investigation of varenicline for heavy drinking smokers

(2011) Lisa M. Fucito et al.   PSYCHOPHARMACOLOGY

Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers

(2009) Sherry A. McKee et al.   BIOLOGICAL PSYCHIATRY

The Smoking Cessation Medication Varenicline Attenuates Alcohol and Nicotine Interactions in the Rat Mesolimbic Dopamine System

(2009) M. Ericson et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS